455 related articles for article (PubMed ID: 16855129)
21. Asthma in USA: its impact on health-related quality of life.
Sullivan PW; Smith KL; Ghushchyan VH; Globe DR; Lin SL; Globe G
J Asthma; 2013 Oct; 50(8):891-9. PubMed ID: 23815682
[TBL] [Abstract][Full Text] [Related]
22. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
23. Estimates of Quality-Adjusted Life-Year Loss for Injuries in the United States.
Raich W; Baxter J; Sheahan M; Goldhaber-Fiebert J; Sullivan P; Hanmer J
Med Decis Making; 2023 Apr; 43(3):288-298. PubMed ID: 36482721
[TBL] [Abstract][Full Text] [Related]
24. Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population.
Lubetkin EI; Jia H; Franks P; Gold MR
Qual Life Res; 2005 Dec; 14(10):2187-96. PubMed ID: 16328899
[TBL] [Abstract][Full Text] [Related]
25. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
Falk Hvidberg M; Brinth LS; Olesen AV; Petersen KD; Ehlers L
PLoS One; 2015; 10(7):e0132421. PubMed ID: 26147503
[TBL] [Abstract][Full Text] [Related]
26. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
27. Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States.
Fu AZ; Qiu Y; Radican L; Luo N
Qual Life Res; 2011 Aug; 20(6):825-32. PubMed ID: 21165701
[TBL] [Abstract][Full Text] [Related]
28. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
29. Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample.
Le QA; Doctor JN
Med Care; 2011 May; 49(5):451-60. PubMed ID: 21422961
[TBL] [Abstract][Full Text] [Related]
30. Do personal and societal preferences differ by socio-demographic group?
Franks P; Lubetkin EI; Melnikow J
Health Econ; 2007 Mar; 16(3):319-25. PubMed ID: 16929479
[TBL] [Abstract][Full Text] [Related]
31. Self-reported chronic conditions and EQ-5D index scores in the US adult population.
Ko Y; Coons SJ
Curr Med Res Opin; 2006 Oct; 22(10):2065-71. PubMed ID: 17031907
[TBL] [Abstract][Full Text] [Related]
32. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
[TBL] [Abstract][Full Text] [Related]
33. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
Nan Luo ; Johnson JA; Shaw JW; Coons SJ
Med Decis Making; 2007; 27(3):321-6. PubMed ID: 17545501
[TBL] [Abstract][Full Text] [Related]
34. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
[TBL] [Abstract][Full Text] [Related]
35. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
[TBL] [Abstract][Full Text] [Related]
36. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
37. Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample.
Wu M; Brazier JE; Kearns B; Relton C; Smith C; Cooper CL
Eur J Health Econ; 2015 Mar; 16(2):141-51. PubMed ID: 24408476
[TBL] [Abstract][Full Text] [Related]
38. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
39. Population norms for the EQ-5D index scores using Singapore preference weights.
Abdin E; Subramaniam M; Vaingankar JA; Luo N; Chong SA
Qual Life Res; 2015 Jun; 24(6):1545-53. PubMed ID: 25394893
[TBL] [Abstract][Full Text] [Related]
40. Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey.
Zhuo L; Xu L; Ye J; Sun S; Zhang Y; Burstrom K; Chen J
Value Health; 2018 Nov; 21(11):1330-1337. PubMed ID: 30442281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
